⏳ Fetching live dividend data...
Home › Calculator › TSSNF Dividend Calculator 2026
Tissue Regenix Group plc · OTC
Price: $0.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TSSNF → $3.6985708459463107e+37M in 10 years · $3,082,134,846,878,647,000,000,000,000,000,000,000,000,000.00/month
Tissue Regenix Group plc, established in Garforth, United Kingdom, in 2006, is a medical technology firm that innovates and markets advanced platform technologies within the fields of tissue engineering and regenerative medicine. The company’s global operations, spanning the United States and other international markets, are managed through its BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions. Central to their offerings are two foundational technologies: dCELL, a sophisticated soft tissue decellularisation process that meticulously extracts DNA and cellular components from animal and human soft tissues to aid in repairing compromised or diseased body parts; and BioRinse, a specialized natural bone filler solution designed to be osteoinductive, thereby stimulating and supporting the regeneration of native bone growth. Their comprehensive product suite includes DermaPure, a decellularised dermal allograft utilized for reinforcing, repairing, or replacing damaged or inadequate integumental tissue, as well as other human integument applications. They also provide SurgiPure XD, a decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects, and OrthoPure XT, a scaffold engineered to replace injured tissue, encouraging repopulation by the patient's own cells. Further products encompass ConCelltrate 100, a certified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic procedures; Matrix IQ Dermis, a human-derived dermal graft that undergoes decellularisation to preserve vital biological properties essential for promoting revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin, pliant demineralised cortical allograft bone sheet. Additionally, the company offers DentalFix, a mineralized particulate allograft that boasts the osteoconductive characteristics of natural bone; a line of CardioPure products; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, serving as a human scaffold for stem cell containment; AmnioWorks, for use in ophthalmology and wound coverage; and various sports medicine solutions.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TSSNF position with:
Real after-tax yield depends on where you live and how you hold TSSNF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 40000.00% | 39997.20% | $4,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 34000.00% | 33997.20% | $3,400,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 32000.00% | 31997.20% | $3,200,000 / yr |
| 🇬🇧 UK ISA | 0% | 40000.00% | 39997.20% | $4,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 36500.00% | 36497.20% | $3,650,000 / yr |
| 🇨🇦 TFSA | 0% | 40000.00% | 39997.20% | $4,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 30000.00% | 29997.20% | $3,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 34000.00% | 33997.20% | $3,400,000 / yr |
| 🇦🇺 AU Taxable | 30% | 28000.00% | 27997.20% | $2,800,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 29450.00% | 29447.20% | $2,945,000 / yr |
| 🇫🇷 FR Taxable | 30% | 28000.00% | 27997.20% | $2,800,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
TSSNF pays quarterly — 4 times per year. Next ex-div: TBD.
How TSSNF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TSSNF sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TSSNF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Tissue Regenix Group plc (TSSNF) is a healthcare stock currently trading at $0.01 with a dividend yield of 40000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →